Mars has obtained unconditional approval from the European Commission to finalize its acquisition of Kellanova, completing all regulatory requirements and setting the expected closing date for December 11, 2025.

The ODP Corporation, parent of Office Depot, is set to be acquired in a $2.6 billion all-cash deal by Atlas Holdings. The agreement will take ODP private, offering shareholders a premium price. This article breaks down the key details, strategic impact, and what's next for stakeholders.

Boeing's acquisition of Spirit AeroSystems is one of the most closely watched moves in the aerospace industry in years. But with FTC-mandated divestitures and a fluctuating share exchange structure, the deal is far from straightforward. Here's what you need to know.

Omnicom Group Inc. and The Interpublic Group of Companies, Inc. (IPG) are set to merge in a major all-stock transaction that will reshape the global advertising industry. Here's a breakdown of the deal, its structure, and implications for stakeholders.

Hanesbrands and Gildan are joining forces in a game-changing merger that’s set to reshape the global apparel industry. From deal structure to shareholder implications, here’s everything you need to know.

Salesforce is making big moves again, acquiring AI-powered data leader Informatica in a major $25 per share cash deal. Here's everything investors, analysts, and tech followers need to know about this strategic acquisition.

On November 13, 2025, Pfizer completed its acquisition of Metsera in a high-stakes biotech merger, offering $65.60 per share in cash and contingent value rights worth up to $20.65. With Metsera now a wholly owned subsidiary and delisted from Nasdaq, here's a full breakdown of what this deal means for shareholders and the future of Pfizer's weight-loss drug strategy.

WK Kellogg Co shareholders approved a $23 per share cash merger with Ferrero International on September 19, 2025. Learn the key terms, shareholder vote results, and what this means for the cereal and confectionery markets.

Skechers is going private. A definitive merger with 3G Capital was announced and is expected to close this September. But there’s more to the story. If you hold Skechers stock, read this before the September 5 election deadline.

In a transformative move that’s set to reshape the U.S. athletic retail landscape, DICK’S Sporting Goods is acquiring Foot Locker for a whopping $4.1 billion. The merger agreement gives shareholders cash or stock options and signals big changes ahead for consumers, investors, and the broader market. Here’s everything you need to know.

The Home Depot is acquiring GMS Inc. in an all-cash tender offer valued at $110 per share. This blog breaks down the deal, what it means for investors, and what steps shareholders need to take now.

Walgreens Boots Alliance has reached a turning point. Shareholders approved its $6.5 billion acquisition by Sycamore Partners, and the transaction is set to close on August 27, 2025. With the deal final, Walgreens stock will be delisted, marking the end of an era for the 120-year-old retail pharmacy giant.

Chevron has completed its high-profile $53 billion acquisition of Hess Corporation after nearly two years of negotiations, regulatory review, and shareholder involvement. This merger marks one of the largest in the oil and gas sector in recent years. Here's a full timeline of the deal, key developments, and what it all means for the future of the energy landscape.

The tech industry is about to witness one of its most significant mergers in recent history. Synopsys, a titan in semiconductor design, is acquiring Ansys, a leader in simulation software. With a deal valued at $35 billion, this merger is set to create a powerful force at the intersection of electronics and physics.

In a bold strategic move, Novartis is acquiring Regulus Therapeutics for up to $1.8 billion. The acquisition centers around farabursen, a novel RNA-based therapy poised to disrupt treatment options for a serious kidney condition called ADPKD. Here's a deep dive into what this merger means for the future of biotech and patient care.

The New Home Company and Landsea Homes have reached a definitive merger agreement valued at approximately $1.2 billion, under which Landsea shareholders will receive $11.30 per share in cash, representing a 61 percent premium to the May 12, 2025 closing price. Backed by Apollo Global Management, this all-cash deal will create a privately held, top-25 national homebuilder with a diversified, asset-light platform spanning ten high-growth markets.

Servotronics and TransDigm have amended their merger agreement to boost the cash tender offer price to $47.00 per share following an unsolicited acquisition proposal. Here is a detailed look at the timeline, mechanics, board endorsement, and what investors should consider.

SRM Entertainment has transformed itself into Tron Inc through a strategic reverse merger, backed by a $100 million equity infusion paid in TRX, a landmark advisory deal with TRON founder Justin Sun, and a blueprint for a TRX Treasury Strategy. In this article, we’ll explore the deal mechanics, what they mean for shareholders, and the path ahead as Tron Inc stakes its claim in the blockchain frontier.

In a landmark deal announced in May 2025, Kronos Bio, Inc. agreed to be acquired by Concentra Biosciences for $0.57 per share in cash plus one contingent value right per share. This comprehensive guide unpacks the transaction’s background, key terms, strategic drivers, and what it means for Kronos’s investors and the broader biotech mergers 2025 landscape.

Redfin and Rocket Companies have agreed to a major merger that could redefine digital real estate. Here's what investors and industry watchers need to know.